Overexpression of c-fos Inhibits Down-Regulation of a Cyclin-Dependent Kinase-2 Inhibitor p27Kip1 in Splenic B Cells Activated by Surface Ig Cross-Linking

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2050-2056

  Kobayashi, Koichi ^a   Phuchareon, Janyaporn ^a   Inada, Kunimasa ^a   Tomita, Yoshitaka ^c   Koizumi, Tamio ^d   Hatano, Masahiko ^a   Miyatake, Shoichiro ^b   Tokuhisa, Takeshi ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d Hyogo Institute of Clinical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CROSS LINKING REAGENT; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; C57BL MOUSE; CELL CYCLE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; ONCOGENE; SPLEEN;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; CELL CYCLE; CELL CYCLE PROTEINS; CROSS-LINKING REAGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENES, FOS; IMMUNOGLOBULIN M; INTERFERONS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; TUMOR SUPPRESSOR PROTEINS;

EID: 0031093501     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Melchers, F., and W. Lenhardt. 1985. Three restriction points in the cell cycle of activated murine B lymphocytes. Proc. Natl. Acad. Sci. USA 82:7681.
2. DeFranco, A. L. 1987. Molecular aspects of B-lymphocyte activation. Annu. Rev. Cell. Biol. 3:143.
3. Buckler, A. J., T. L. Rothstein, and G. E. Sonenshein. 1990. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes. J. Immunol. 145:732.
4. Seyfert, V. L., S. McMahon, W. Glenn, X. M. Cao, V. P. Sukhatme, and J. G. Monroe. 1990. Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation. J. Immunol. 145:3647.
5. Klemsz, M. J., L. B. Justement, E. Palmer, and J. C. Cambier. 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143:1032.
6. Koizumi, T., Y. Ochi, S. Kobayashi, M. Nakanishi, and T. Tokuhisa. 1994. Deregulated expression of c-fos disturbs proliferative responses of B cells to sIg cross-linking. Cell. Immunol. 155:384.
7. Monroe, J. G. 1988. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation. J. Immunol. 140:1454.
8. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059.
9. Ohtsubo, M., A. M. Thedoras, J. Schumacher, J. M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612.
10. Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and G. Draetta. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured in human fibroblasts. J. Cell Biol. 121:101.
11. Tsai, L. H., E. Lees, B. Faha, and E. Harlow. 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogens 8:1593.
12. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050.
13. Gu, Y., C. W. Turek, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707.
14. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805.
15. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, D. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701.
16. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
17. Kip1, a cyclin dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
18. Toyashioma, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67.
19. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639.
20. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650.
21. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149.
22. Bachiller, D., and U. Rüther. 1990. Inducible expression of the proto-oncogene c-fos in transgenic mice. Arch. Geschwulstforsh. 60:357.
23. Takada, M., T. Koizumi, D. Bachiller, U. Rüther, and T. Tokuhisa. 1993. Deregulated c-fos augments cell proliferation of B cells mediated by lipopolysaccharide. Cancer Lett. 68:243.
24. Takao, S., N. Sakai, M. Hatano, K. Hanioka, U. Rüther, and T. Tokuhisa. 1991. The IgG response is impaired in H2-c-fos transgenic mice. Int. Immunol. 3:369.
25. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
26. Ochi, Y., T. Koizumi, S. Kobayashi, J. Phuchareon, M. Hatano, M. Takada, Y. Tomita, and T. Tokuhisa. 1994. Analysis of IL-2 gene regulation in c-fos transgenic mice: evidence for an enhancement of IL-2 expression in splenic T cells stimulated via TCR/CD3 complex. J. Immunol. 153:3485.
27. 32P-base hybridizations. Anal. Biochem. 210:235.
28. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066.
29. 1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 156:4562.
30. Noguchi, E., T. Sekiguchi, K. Yamashita, and T. Nishimoto. 1993. Molecular cloning and identification of two types of hamster cyclin-dependent kinases: cdk2 and cdk2L. Biochem. Biophys. Res. Commun. 197:1524.
31. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018.
32. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. D. Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682.
33. 0-like arrest. Mol. Cell. Biol. 16:3934.
34. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1071:129.
35. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889.
36. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
37. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487.
38. Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877.